Speaker Profile
Ph.D., Vice President, Research & Development, Castle Biosciences
Biography
Dr. Rebecca Critchley-Thorne joined Castle Biosciences in December 2021 as Vice President, RD, Spatialomics and GI, as part of the acquisition of Cernostics Inc., where she was Co-Founder and Chief Scientific Officer. She led the development of the Tissue Cypher computational pathology platform as well as the Tissue Cypher Barretts Esophagus test and its supporting clinical studies. She currently oversees RD for Castles commercially available tests and pipeline activities. She completed training as a postdoctoral fellow at Stanford University, where she focused on highly multiplexed analysis of biomarkers to understand mechanisms of immune dysfunction in various cancer types. She completed doctoral work in cancer immunotherapy at Imperial College and Cancer Research UK in London, UK, and earned a B. S. (Hons) degree in Pharmacology from the University of Sheffield, UK. Dr. Critchley-Thorne is the author of many medical and scientific publications, a principal investigator on NIH-funded research studies, and an inventor on several of Castle's patents.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Christina Curtis, Stanford
PMWC Award Ceremony
• W.E. Moerner, Stanford
• Serge Saxonov, 10x Genomics
• Priscilla Chan, Biohub
Honoree Fireside
• Christina Curtis, Stanford
• Priscilla Chan, Biohub
Honoree Fireside: From Measurement to Meaning: What Data AI Still Needs in Biology
• Christina Curtis, Stanford
• W.E. Moerner, Stanford
• Serge Saxonov, 10x Genomics
Unraveling Tissue Architecture with Single-Cell & Spatial Multi-Omics
• Chair: Garry P. Nolan, Stanford
• Joakim Lundeberg, SciLifeLab
• Tae Hyun Hwang, Vanderbilt University Medical Center
• Michael Angelo, Stanford
Spatial Sequencing for Next Generation Pathology
• Eli Glezer, Singular Genomics
Precision Profiling of Cells: Insights from Imaging-Spectral Flow Cytometry and Single-Cell Multiomics
• Aruna Ayer, BD
Single-Cell Genotype and Targeted Gene Expression Assay
• Zivjena Vucetic, Mission Bio
Resolving Cellular Lineage and State in Tumors with High-Resolution Single-Cell Genomics
• Gary Schroth, Cellanome
From Cellular State to Disease Gene Prediction at Population Scale
• Kyle Farh, Illumina
Tumor Evolution & Clonal Dynamics: From Models to Monitoring
• Christina Curtis, Stanford
Personal Omics at Scale: What Longitudinal Profiles Add to Early Detection
• Michael Snyder, Stanford
Multi-Omics-Driven Early Detection: Beyond Liquid Biopsy
• Chair: Alex Aravanis, Moonwalk Biosciences
• Ash Alizadeh, Stanford
• Sara Ahadi, OmicsEra
AI in Molecular Diagnostics: Integrating Multi-Omics & Clinical Data
• Chair: Marina Sirota, UCSF
• Olivier Gevaert, Stanford
• Rebecca Critchley-Thorne, Castle Biosciences
• Lihua Jiang, Stanford
• Yunguan Wang, Cincinnati Children's
